Clinical significance of cyclin B1 and cyclin-dependent kinase 1 expression in human esophageal squamous cell carcinoma

World Chinese Journal of Digestology

Volumn 17, Issue 23, 2009, Pages 2374-2378

  Zhao, Chun Ling ^a   Chen, Li Mei ^a   Gao, Zhi Qin ^a   Du, Chang Qing ^a   Pan, Zhi Fang ^a   Yu, Wen Jing ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Cyclin B1; Cyclin dependent kinase 1; Esophageal squamous cell carcinoma; Immunohistochemistry

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE 1;

AGE DISTRIBUTION; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; SEX RATIO;

EID: 75149180984     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v17.i23.2374     Document Type: Article

References (22)

1. Dawsey SM, Lewin KJ, Wang GQ, Liu FS, Nieberg RK, Yu Y, Li JY, Blot WJ, Li B, Taylor PR. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 1994; 74: 1686-1692
2. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000; 60: 3689-3695
3. Ohi R, Gould KL. Regulating the onset of mitosis. Curr Opin Cell Biol 1999; 11: 267-273
4. Norbury C, Nurse P. Animal cell cycles and their control. Annu Rev Biochem 1992; 61: 441-470
5. Kim DH. Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer. Yonsei Med J 2007; 48: 694-700
6. Chen H, Huang Q, Dong J, Zhai DZ, Wang AD, Lan Q. Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo. BMC Cancer 2008; 8: 29
7. Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura M, Yamada T, Nawata H, Tsuneyoshi M. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol 2005; 36: 828-837
8. Ito Y, Yoshida H, Nakano K, Takamura Y, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A. Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation. Pathol Res Pract 2002; 198: 397-402
9. Jin YH, Park CK. Expression of cyclin B1 and cdc2 in nodal non-Hodgkin's lymphoma and its prognostic implications. J Korean Med Sci 2002; 17: 322-327
10. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Müller W. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 2002; 94: 2874-2881
11. Nozoe T, Takahashi I , Baba H, Maehara Y. Relationship between intracellular localization of p34cdc2 protein and differentiation of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2005; 131: 179-183
12. Hao XP, Pretlow TG, Rao JS, Pretlow TP. Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 2001; 61: 8085-8088
13. Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res 2001; 7: 2458-2462
14. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 2000; 60: 4000-4004
15. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H. The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol 2004; 15: 252-256
16. Kushner J , Bradley G, Young B, Jordan RC. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J Oral Pathol Med 1999; 28: 77-81
17. Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. Cancer Lett 2002; 177: 13-19
18. Kaczmarek P, Tos ik D, Majewska E, Baj Z. Quantitative analysis of cyclin E and protein p34 cdc2 expression in superficial bladder cancer. Pol J Pathol 2006; 57: 41-44
19. Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology 2000; 59: 68-74
20. Hansel DE, Dhara S, Huang RC, Ashfaq R, Deasel M, Shimada Y, Bernstein HS, Harmon J, Brock M, Forastiere A, Washington MK, Maitra A, Montgomery E. CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. Am J Surg Pathol 2005; 29: 390-399
21. Mandard AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 2000; 462: 335-342
22. Stoner GD, Gupta A. Etiology and chemoprevention of esophageals quamous cell carcinoma. Carcinogenesis 2001; 22: 1737-1746